B Bilgin Global Mod Global Mod 10 Ağu 2023 #1 JB Pharma reports a 35% YoY increase in Q1 PAT The company’s domestic formulation segment saw a growth of 17% to stand at ₹489 crore in the first quarter of the current fiscal year
JB Pharma reports a 35% YoY increase in Q1 PAT The company’s domestic formulation segment saw a growth of 17% to stand at ₹489 crore in the first quarter of the current fiscal year
